89 related articles for article (PubMed ID: 11977304)
1. Activity of Tumor Necrosis Factor-alfa (TNF-alpha) and selected acute phase proteins in plasma of psoriatic patients receiving local treatment.
Chodorowska G; Juszkiewicz-Borowiec M; Czelej D; Wojnowska D; Kowal M
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():165-9. PubMed ID: 11977304
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
Chodorowska G; Czelej D
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
Czelej D; Chodorowska G; Lechowska-Mazur I
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
[TBL] [Abstract][Full Text] [Related]
4. Plasma activity of interleukin-6 and some acute phase proteins in severe drug-induced skin adverse reactions.
Czelej D; Chodorowska G; Lecewicz-Toruń B
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):62-7. PubMed ID: 12898820
[TBL] [Abstract][Full Text] [Related]
5. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
6. Acute phase proteins in psoriasis.
Biljan D; Situm M; Kostović K; Batinac T; Matisić D
Coll Antropol; 2009 Mar; 33(1):83-6. PubMed ID: 19408608
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment.
Chodorowska G
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):147-51. PubMed ID: 9553912
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis.
Chodorowska G; Wojnowska D; Juszkiewicz-Borowiec M
J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):180-3. PubMed ID: 15009298
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and some acute phase proteins plasma activity in drug-induced maculopapular eruptions.
Chodorowska G; Czelej D; Roguś-Skorupska D
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):180-4. PubMed ID: 16145976
[TBL] [Abstract][Full Text] [Related]
10. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
11. Study on activity of interleukin-6, C-reactive protein and alpha-2 macroglobulin in psoriatic patients during the acute clinical stage and remission.
Chodorowska G; Czelej D; Borowiec M; Pietrzak A; Krasowska D; Kowal M
Ann Univ Mariae Curie Sklodowska Med; 2000; 55():29-36. PubMed ID: 11482089
[No Abstract] [Full Text] [Related]
12. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
Serwin AB; Wasowicz W; Chodynicka B
Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
[TBL] [Abstract][Full Text] [Related]
13. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
[TBL] [Abstract][Full Text] [Related]
14. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome.
Beijing Group of National Research Project for SARS
Chin Med J (Engl); 2003 Sep; 116(9):1283-7. PubMed ID: 14527349
[TBL] [Abstract][Full Text] [Related]
16. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
Martínez-Borra J; López-Larrea C; González S; Fuentes D; Dieguez A; Deschamps EM; Pérez-Pariente JM; López-Vázquez A; de Francisco R; Rodrigo L
Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
[TBL] [Abstract][Full Text] [Related]
17. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
[TBL] [Abstract][Full Text] [Related]
18. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
[TBL] [Abstract][Full Text] [Related]
19. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
[TBL] [Abstract][Full Text] [Related]
20. Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions.
Chodorowska G; Czelej D; Niewiedzioł M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):50-6. PubMed ID: 15323166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
